Avidity Partners Management LP Biomarin Pharmaceutical Inc Transaction History

Avidity Partners Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $26.4 Million - $35.2 Million	300,575 New	300,575 $29.2 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $74.2 Million - $90 Million	-992,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $72.1 Million - $89.6 Million	992,900 New	992,900 $87.1 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $24 Million - $37.5 Million	-302,000 Closed	0 $0
Q1 2020 Jun 17, 2020	BUY	$71.37 - $96.85 $21.6 Million - $29.2 Million	302,000 New	302,000 $25.5 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.